Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, Mohamed Y Abuzeid, Saxby Pridmore
{"title":"皮卡的精神药物疗法--我们知道多少？","authors":"Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, Mohamed Y Abuzeid, Saxby Pridmore","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>There is little evidence for psychopharmacotherapy in pica. A few studies reported some benefit from the use of SSRIs, atypical antipsychotics and methylphenidate. That said, evidence to deploy these agents remains, at large, flimsy. Here, despite scarcity, we review available literature and draw some generalities that can inform decision-making on clinical grounds.</p>","PeriodicalId":94351,"journal":{"name":"Psychopharmacology bulletin","volume":"54 4","pages":"119-123"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385262/pdf/","citationCount":"0","resultStr":"{\"title\":\"Psychopharmacotherapy of Pica-<i>How Much Do We Know</i>?\",\"authors\":\"Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, Mohamed Y Abuzeid, Saxby Pridmore\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There is little evidence for psychopharmacotherapy in pica. A few studies reported some benefit from the use of SSRIs, atypical antipsychotics and methylphenidate. That said, evidence to deploy these agents remains, at large, flimsy. Here, despite scarcity, we review available literature and draw some generalities that can inform decision-making on clinical grounds.</p>\",\"PeriodicalId\":94351,\"journal\":{\"name\":\"Psychopharmacology bulletin\",\"volume\":\"54 4\",\"pages\":\"119-123\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11385262/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharmacology bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Psychopharmacotherapy of Pica-How Much Do We Know?
There is little evidence for psychopharmacotherapy in pica. A few studies reported some benefit from the use of SSRIs, atypical antipsychotics and methylphenidate. That said, evidence to deploy these agents remains, at large, flimsy. Here, despite scarcity, we review available literature and draw some generalities that can inform decision-making on clinical grounds.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
